TREATMENT WITH ŒSTROGENS OF PRIMARY HYPERPARATHYROIDISM IN POST-MENOPAUSAL WOMEN

J. C. Gallagher, B. E.C. Nordin

Research output: Contribution to journalArticle

80 Scopus citations

Abstract

Ethinylœstradiol was administered to 10 post-menopausal hyperparathyroid patients. There was a gradual fall in the fasting plasma-calcium and urine-calcium and in the 24-hour- urine calcium and hydroxyproline, which was maintained up to one year in the patients who continued therapy. Œstrogen treatment of hyperparathyroidism in post-menopausal women might be expected to prevent bone disease by inhibiting bone resorption, and stone disease by reducing urine-calcium.

Original languageEnglish (US)
Pages (from-to)503-507
Number of pages5
JournalThe Lancet
Volume299
Issue number7749
DOIs
StatePublished - Mar 4 1972

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this